Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 12

    1.

    Hypertensive choroidopathy: recognizing clinically significant end-organ damage.

    Ugarte M, Horgan S, Rassam S, Leong T, Kon CH.

    Acta Ophthalmol. 2008 Mar;86(2):227-8. Epub 2007 Sep 21. No abstract available. PMID: 17888082 [PubMed - indexed for MEDLINE]Related articles

    2.

    Intraoperative floppy-iris syndrome, alpha1-adrenergic antagonists, and chronic intake of mianserin: is there an association?

    Ugarte M, Leong T, Rassam S, Kon CH.

    J Cataract Refract Surg. 2007 Jan;33(1):170. No abstract available. PMID: 17189819 [PubMed - indexed for MEDLINE]Related articles

    3.

    Silicone oil concentrates fibrogenic growth factors in the retro-oil fluid.

    Asaria RH, Kon CH, Bunce C, Sethi CS, Limb GA, Khaw PT, Aylward GW, Charteris DG.

    Br J Ophthalmol. 2004 Nov;88(11):1439-42.PMID: 15489490 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Matrix metalloproteinases: a role in the contraction of vitreo-retinal scar tissue.

    Sheridan CM, Occleston NL, Hiscott P, Kon CH, Khaw PT, Grierson I.

    Am J Pathol. 2001 Oct;159(4):1555-66.PMID: 11583981 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    How to predict proliferative vitreoretinopathy: a prospective study.

    Asaria RH, Kon CH, Bunce C, Charteris DG, Wong D, Luthert PJ, Khaw PT, Aylward GW.

    Ophthalmology. 2001 Jul;108(7):1184-6.PMID: 11425672 [PubMed - indexed for MEDLINE]Related articles

    6.

    Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy : Results from a randomized, double-blind, controlled clinical trial.

    Asaria RH, Kon CH, Bunce C, Charteris DG, Wong D, Khaw PT, Aylward GW.

    Ophthalmology. 2001 Jul;108(7):1179-83.PMID: 11425671 [PubMed - indexed for MEDLINE]Related articles

    7.

    Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study.

    Kon CH, Asaria RH, Occleston NL, Khaw PT, Aylward GW.

    Br J Ophthalmol. 2000 May;84(5):506-11.PMID: 10781515 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study.

    Kon CH, Occleston NL, Aylward GW, Khaw PT.

    Invest Ophthalmol Vis Sci. 1999 Mar;40(3):705-12.PMID: 10067974 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effects of single, short-term exposures of human retinal pigment epithelial cells to thiotepa or 5-fluorouracil: implications for the treatment of proliferative vitreoretinopathy.

    Kon CH, Occleston NL, Foss A, Sheridan C, Aylward GW, Khaw PT.

    Br J Ophthalmol. 1998 May;82(5):554-60.PMID: 9713065 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy.

    Kon CH, Occleston NL, Charteris D, Daniels J, Aylward GW, Khaw PT.

    Invest Ophthalmol Vis Sci. 1998 Jul;39(8):1524-9.PMID: 9660504 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    A new colour vision test for clinical use.

    Kon CH, De Alwis D.

    Eye (Lond). 1996;10 ( Pt 1):65-74.PMID: 8763306 [PubMed - indexed for MEDLINE]Related articles

    12.

    A new way to use the Ishihara test.

    de Alwis DV, Kon CH.

    J Neurol. 1992 Oct;239(8):451-4.PMID: 1447573 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...